Talk:Avelumab
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Avelumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Avelumab.
|
Should add which confirmatory studies
The FDA accelerated approval is conditional on further confirmatory studies being successful. Could identify the studies and likely reporting dates. - Rod57 (talk) 12:28, 24 July 2017 (UTC)
Other approvals for eg Merkel Cell carcinoma
Sometime in 2017 it was approved by Switzerland, and now in the EU (for Merkel Cell carcinoma) - says [1]. - Rod57 (talk) 12:24, 22 September 2017 (UTC)
[2] says also approved by FDA in May for Bladder cancer. - Rod57 (talk) 12:40, 22 September 2017 (UTC)